Quarterly Result12 Aug 2025, 01:20 pm
Marksans Pharma Ltd. Announces Q1 2025 Financial Results with 11.74% Increase in Revenue
AI Summary
Marksans Pharma Ltd. announced its unaudited financial results for the quarter ended June 30, 2025. The company's revenue from operations stood at 3,197.34 million, marking a 20.10% increase from the same period last year. The net profit for the quarter was 453.16 million, a slight increase from the previous quarter. The company operates in the pharmaceuticals segment and has subsidiaries in various countries. The audit committee and the board of directors have reviewed these results.
Key Highlights
- Revenue from operations increased by 20.10% compared to the same period last year.
- Net profit for the quarter was 453.16 million.
- The company operates in the pharmaceuticals segment.
- Results reviewed by the audit committee and the board of directors.
- The company has subsidiaries in various countries.